In the past decade, there have been significant advancements in targeted antibody-based immunotherapies for managing r/r ...

A liver-first treatment approach in primary and colorectal liver metastases (CRLM) is associated with worse recurrence-free survival (RFS) than primary-first or simultaneous treatment approaches, ...

Patients who achieved a pathologic complete response after neoadjuvant therapy had better survival outcomes than patients who received adjuvant therapy.

Ovarian cancer detected with specificity >99 percent and sensitivity ranging from 69 to 100 percent depending on stage.